Show simple item record

dc.contributor.authorSuárez Obando, Fernando
dc.date.accessioned2021-02-02T14:21:35Z
dc.date.available2021-02-02T14:21:35Z
dc.date.issued2020-11-17
dc.identifier.citationSuárez-Obando F. Investigación clínica y buenas prácticas clínicas. Más historias por contar. 2020; 24(2): 188-204. DOI: https://doi.org/10.5294/pebi.2020.24.2.6es_CO
dc.identifier.issn0123-3122
dc.identifier.otherhttps://personaybioetica.unisabana.edu.co/index.php/personaybioetica/article/view/12131
dc.identifier.urihttp://hdl.handle.net/10818/46626
dc.description17 páginases_CO
dc.description.abstractCon el objetivo de garantizar la conducción ética de la investigación científica en seres humanos y que en su ejecución prevalezcan el interés por la salud y el bienestar de los sujetos participantes, se han desarrollado diversas pautas, normas y parámetros dirigidos a la comunidad científica que implementa la investigación en estos sujetos. Uno de esos parámetros normativos es el de las buenas prácticas clínicas, el cual, luego de su implementación a través de la Resolución 2378 de 2008, se ha convertido en un documento orientador de gran relevancia para la investigación clínica en Colombia. El presente artículo relata sus orígenes y versiones, y reflexiona sobre sus limitaciones frente al debate ético que gira alrededor de la evaluación de protocolos de investigación por parte de los comités de ética.spa
dc.description.abstractFor guaranteeing the ethical conduct of scientific research on human beings in which the interest in the health and well-being of the participating subjects prevail, various guidelines, standards, and parameters have been established for the scientific community. One of these regulatory parameters is good clinical practice, which, after its implementation by Resolution 2378 of 2008, has become a highly relevant guide for clinical trials in Colombia. This article relates its origins and versions and goes over its limitations regarding the ethical debate on ethics committees evaluating research protocols.eng
dc.description.abstractCom o objetivo de garantir a condução ética da pesquisa científica em seres humanos e que em sua execução prevaleça o interesse pela saúde e pelo bem-estar dos sujeitos participantes, foram desenvolvidas diversas pautas, normas e parâmetros dirigidos à comu-nidade científica que implementa a pesquisa nesses sujeitos. Um desses parâmetros normativos é o das boas práticas clínicas, o qual, depois de sua implementação por meio da Resolução 2378 de 2008, tornou-se um documento orientador de grande relevância para a pesquisa clínica na Colômbia. O presente artigo relata suas origens e versões, e reflete sobre suas limitações com relação ao debate ético que gira em torno da avaliação de protocolos de pesquisa, por parte dos comitês de ética.por
dc.formatapplication/pdfes_CO
dc.language.isospaes_CO
dc.publisherUniversidad de La Sabanaes_CO
dc.relation.ispartofseriesPers Bioet. 2020;24(2): 188-204
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.sourceinstname:Universidad de La Sabanaes_CO
dc.sourcereponame:Intellectum Repositorio Universidad de La Sabanaes_CO
dc.subject.otherInvestigaciónspa
dc.subject.otherÉtica en investigaciónspa
dc.subject.otherComités de éticaspa
dc.titleInvestigación clínica y buenas prácticas clínicas. Más historias por contares_CO
dc.title.alternativeClinical Research and Good Clinical Practice. More Stories to Telles_CO
dc.title.alternativePesquisa clínica e boas práticas clínicas. Mais histórias por contares_CO
dc.typearticlees_CO
dc.publisher.departmentDirección de Publicaciones
dc.type.hasVersionpublishedVersiones_CO
dc.rights.accessRightsopenAccesses_CO
dc.identifier.doihttps://doi.org/10.5294/pebi.2020.24.2.6
dcterms.referencesKim WO. Institutional review board (IRB) and ethical issues in clinical research. Korean J Anesthesiol. 2012;62(1):3-12. DOI: https://doi.org/10.4097/kjae.2012.62.1.3eng
dcterms.referencesTannert C, Elvers HD, Jandrig B. The ethics of uncertainty. In the light of possible dangers, research becomes a moral duty. EMBO Rep. 2007;8(10):892-6. DOI: https://doi.org/10.1038/sj.embor.7401072eng
dcterms.referencesSuárez-Obando F. Consentimiento informado como criterio de inclusión. ¿Confusión conceptual, manipulación, discriminación o coerción? Pers y Bioét. 2016;20(2):244-56. DOI: https://doi.org/10.5294/pebi.2016.20.2.9spa
dcterms.referencesSchatz GS. Are the rationale and regulatory system for protecting human subjects of biomedical and behavioral research obsolete and unworkable, or ethically important but inconvenient and inadequately enforced? J Contemp Health Law Policy. 2003;20(1):1-31. Disponible en: https://pubmed.ncbi.nlm.nih.gov/15067927/eng
dcterms.referencesSharp RR, Taylor HA, Brinich MA, Boyle MM, Cho M, Coors M, et al. Research ethics consultation: ethical and professional practice challenges and recommendations. Acad Med. 2015;90(5):615-20. DOI: https://doi.org/10.1097/ACM.0000000000000640eng
dcterms.referencesDixon JR Jr. The international conference on harmonization good clinical practice guideline. Qual Assur. 1998;6(2):65-74. DOI: https://doi.org/10.1080/105294199277860eng
dcterms.referencesPalacios M. Las buenas prácticas clínicas en Colombia. Colombia Medica. 2009;39(4):312-3.spa
dcterms.referencesVray M, Simon F, Bompart F. Participants in Round Table N masculine GX. Guidelines for clinical research in developing countries. Therapie. 2007;62(3):223-7.eng
dcterms.referencesCrofton J. The MRC randomized trial of streptomycin and its legacy: A view from the clinical front line. J R Soc Med. 2006;99(10):531-4. DOI: https://doi.org/10.1258/jrsm.99.10.531eng
dcterms.referencesDaniels M, Hill AB. Chemotherapy of pulmonary tuberculosis in young adults; an analysis of the combined results of three Medical Research Council trials. Br Med J. 1952;1(4769):1162-8. DOI: https://doi.org/10.1136/bmj.1.4769.1162eng
dcterms.referencesGrabowsky H. The evolution of the pharmaceutical industry over the past 50 years: A personal reflection. Int J of Economic Bussines. 2011;18(2):161-76. DOI: https://doi.org/10.1080/13571516.2011.584421eng
dcterms.referencesWax PM. Elixirs, diluents, and the passage of the 1938 Federal Food, Drug and Cosmetic Act. Ann Intern Med. 1995;122(6):456-61. DOI: https://doi.org/10.7326/0003-4819-122-6-199503150-00009eng
dcterms.referencesBorchers AT, Hagie F, Keen CL, Gershwin ME. The history and contemporary challenges of the US Food and Drug Administration. Clin Ther. 2007;29(1):1-16. DOI: https://doi.org/10.1016/j.clinthera.2007.01.006eng
dcterms.referencesTurner JR. The 50th anniversary of the Kefauver-Harris Amendments: Efficacy assessment and the randomized clinical trial. J Clin Hypertens (Greenwich). 2012;14(11):810-5. DOI: https://doi.org/10.1111/jch.12012eng
dcterms.referencesKim JH, Scialli AR. Thalidomide: The tragedy of birth defects and the effective treatment of disease. Toxicol Sci. 2011;122(1):1-6. DOI: https://doi.org/10.1093/toxsci/kfr088eng
dcterms.referencesLachmann PJ. The penumbra of thalidomide, the litigation culture and the licensing of pharmaceuticals. QJM. 2012;105(12):1179-89. DOI: https://doi.org/10.1093/qjmed/hcs148eng
dcterms.referencesRidings JE. The thalidomide disaster, lessons from the past. Methods Mol Biol. 2013;947:575-86. DOI: https://doi.org/10.1007/978-1-62703-131-8_36eng
dcterms.referencesGreene JA, Podolsky SH. Reform, regulation, and pharmaceuticals--the Kefauver-Harris Amendments at 50. N Engl J Med. 2012;367(16):1481-3. DOI: https://dx.doi.org/10.1056/NEJMp1210007eng
dcterms.referencesBaron JH. Evolution of clinical research: a history before and beyond James Lind. Perspect Clin Res. 2012;3(4):149. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3149409/eng
dcterms.referencesHellmann F, Verdi M, Schlemper BR Jr., Caponi S. 50th anniversary of the Declaration of Helsinki: the double standard was introduced. Arch Med Res. 2014;45(7):600-1. DOI: http://doi.org/10.1016/j.arcmed.2014.10.005eng
dcterms.referencesDepartment of Health E, Welfare, National Commission for the Protection of Human Subjects of B, Behavioral R. The Belmont Report. Ethical principles and guidelines for the protection of human subjects of research. J Am Coll Dent. 2014;81(3):4-13. Disponible en: https://pubmed.ncbi.nlm.nih.gov/25951677/eng
dcterms.referencesBeecher HK. Ethics and clinical research. N Engl J Med. 1966;274(24):1354-60. DOI: https://doi.org/10.1056/NEJM196606162742405eng
dcterms.referencesten Have HA. Potter’s notion of bioethics. Kennedy Inst Ethics J. 2012;22(1):59-82. DOI: https://doi.org/10.1353/ken.2012.0003eng
dcterms.referencesMasuyama K, Isobe S. Social change and Pharmaceutical Affairs Law (PAL). Yakushigaku Zasshi. 2010;45(1):78-81. Disponible en: https://pubmed.ncbi.nlm.nih.gov/21032892/eng
dcterms.referencesCouncil Directive 65/65/EEC of 26 January 1965 on the approximation of provisions laid down by Law, Regulation or Administrative Action relating to proprietary medicinal products. 1965.eng
dcterms.referencesUmemura M. A historical overview of Japan´s pharmaceutical industry.The japanese pharmaceutical industry: its evolution and current challenges. New York: Routledge; 2011;16-7.eng
dcterms.referencesWorld Health Organization (WHO). Principles for the cinical evaluation of drugs. World Health Organization technical report series. No. 403. Geneva: World Health Organization; 1968.eng
dcterms.referencesWorld Health Organization (WHO). Principles for the cinical evaluation of drugs. World Health Organization technical report series. No. 563. Geneva: World Health Organization; 1975.eng
dcterms.referencesInternational Council for Harmonisation (ICH). The need to harmonise. Disponible en: http://www.ich.org/about/history.htmleng
dcterms.referencesEuropean Medicines Evaluation Agency (EMA). European Medicines Evaluation Agency and the new licensing arrangements. Drug Ther Bull. 1994;32(12):89-90. DOI: https://doi.org/10.1136/dtb.1994.321289eng
dcterms.referencesSauer F, Hankin R. Rules governing pharmaceuticals in the European Community. J Clin Pharmacol. 1987;27(9):639-46. DOI: https://doi.org/10.1002/j.1552-4604.1987.tb03081.xeng
dcterms.referencesVijayananthan A, Nawawi O. The importance of Good Clinical Practice guidelines and its role in clinical trials. Biomed Imaging Interv J. 2008;4(1):e5. DOI: https://doi.org/10.2349/biij.4.1.e5eng
dcterms.referencesWorld Health Organization (WHO). Fifth International Conference of Drug Regulatory Authorities. Geneva: World Health Organization; 1991.eng
dcterms.referencesInternational Council for Harmonisation (ICH). International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) adopts consolidated guideline on good clinical practice in the conduct of clinical trials on medicinal products for human use. Int Dig Health Legis. 1997;48(2):231-4. Disponible en: https://pubmed.ncbi.nlm.nih.gov/11656783/eng
dcterms.referencesCartwright A. The common technical document - a global format for registration files. En: Cartwright A, Matthews B, editores. International Pharmaceutical Product Registration. 2 ed. Boca Raton, Fl: CRC Press; 2010. p. 1-2.eng
dcterms.referencesSmith PF. Third international conference on harmonization of technical requirements for registration of pharmaceuticals for human use--a toxicologist’s perspective. Toxicol Pathol. 1996;24(4):519-28. DOI: https://doi.org/10.1177/019262339602400423eng
dcterms.referencesHorton LR. Harmonization, regulation, and trade: where do we go from here? PDA J Pharm Sci Technol. 1996;50(1):61-5. Disponible en: https://pubmed.ncbi.nlm.nih.gov/8846062/eng
dcterms.referencesOhno Y. ICH guidelines—implementation of the 3Rs (refinement, reduction, and replacement): incorporating best scientific practices into the regulatory process. ILAR J. 2002;43 Suppl:S95-8. DOI: https://doi.org/10.1093/ilar.43.suppl_1.s95eng
dcterms.referencesCalam DH. Design and international harmonization of pharmacopoeial standards. J Pharm Biomed Anal. 1995;14(1-2):1-5. DOI: https://doi.org/10.1016/0731-7085(95)01578-7eng
dcterms.referencesInternational Council for Harmonisation (ICH). ICH Harmonised Tripartite Guideline. Guideline for Good Cinical Practice E6(R1). Geneva: ICH; 1996.eng
dcterms.referencesInternational Council for Harmonisation (ICH). ICH Harmonised Tripartite Guideline. Guideline for Good Cinical Practice E6(R2). Geneva: ICH; 2015.eng
dcterms.referencesWorld Health Organization (WHO). Guidelines for Good Clinical Practice (GCP) for trials on pharmaceutical products. WHO. Technical report series, No. 850, Annex 3 - WHO Expert committee on selection and use of essential medicines, Sixth Report, 1993. Geneva: World Health Organization; 1995.eng
dcterms.referencesIdanpaan-Heikkila JE. WHO guidelines for good clinical practice (GCP) for trials on pharmaceutical products: responsibilities of the investigator. Ann Med. 1994;26(2):89-94. DOI: https://doi.org/10.3109/07853899409147334eng
dcterms.referencesWorld Health Organization (WHO). Handbook for good clinical research practice (GCP): guidance for implementation. World Health Organization; 2005.eng
dcterms.referencesOsorio L. What everybody should know about good clinical practices. Biomedica. 2015;35(2):274-84. DOI: https://doi.org/10.7705/biomedica.v35i2.2404eng
dcterms.referencesPan American Health Organization (PAHO-WHO). Conferencia Panamericana sobe Armonización de la Reglamentación Farmacéutica; 1998.spa
dcterms.referencesPan American Health Organization (PAHO-WHO). IV Conferencia Panamericana sobe Armonización de la Reglamentación Farmacéutica; 2005.spa
dcterms.referencesOrganización Panamericana de la Salud (OPS-WHO). Buenas Prácticas Clínicas: Documento de las Américas; 2005.spa
dcterms.referencesWorld Health Organization (WHO). Operational guidelines for ethics committees that review biomedical research. Geneva: World Health Organization; 2000.eng
dcterms.referencesVidal S. Comités de ética de la investigación. En: Tealdi J, Saada A, editores. Diccionario Latinoamericano de Bioética. Bogotá D.C.: Universidad Nacional de Colombia UNIBIBLOS; 2008. p. 107-15.spa
dcterms.referencesLozano-León J, Rojas M. Informe Final AsesoríaConvenio 245 de 2004 suscrito entre la Pontificia Universidad Javeriana y el Ministerio de la Protección Social para el “Diseño, elaboración y validación de las normas de buena práctica clínica para centros que conducen investigación de medicamentos en sujetos humanos”. Bogotá: PUJ; 2005.spa
dcterms.referencesInvima. Investigación Clínica. Instituciones certificadas en buenas prácticas clínicas 2019. Disponible en: https://www.invima.gov.co/buenas-Practicas-clinicas-invima#protocolos-de-investigaci%C3%B3n-cl%C3%ADnicaspa
dcterms.referencesInvima. Investigación Clínica. Comités de ética vinculados a instituciones certificadas en buenas prácticas clínicas 2019. Disponible en: https://www.invima.gov.co/buenas-Practicas-clinicas-invima#protocolos-de-investigaci%C3%B3n-cl%C3%ADnicaspa
dcterms.referencesRomero GA. Clinical research monitoring: scenarios and challenges. Rev Soc Bras Med Trop. 2013;46(1):3-6. https://doi.org/10.1590/0037-868217342013eng
dcterms.referencesRepública de Colombia. Ministerio de Protección Social. Resolución 2378 de 2008. Por la cual se adoptan las Buenas Prácticas Clínicas para las instituciones que conducen investigación con medicamentos en seres humanos; 2008.spa
dcterms.referencesAvanzar. Cursos Básicos BPC 2019. Disponible en: http://www.avanzar.com.co/index.php/educacion-continuadaspa
dcterms.referencesFundación Universitaria de Ciencias de la Salud (FUCS). Curso de Buenas Prácticas Clínicas (BPC) 2019. Disponible en: http://www.fucsalud.edu.co/index.php/es/administrativos-cursos/357-curso-de-buenas-practicas-clinicas?template=fucsalud-contenidospa
dcterms.referencesUniversidad CES. Curso buenas prácticas clínicas 2016. Disponible en: https://www.ces.edu.co/educacion-continua/curso/curso-buenas-practicas-clinicas-virtual-3/spa
dcterms.referencesInfonetica. Online GCP 2019. Disponible en: http://www.onlinegcp.com/spa
dcterms.referencesNational Institutes of Health (NIH). The Good Clinical Practice (GCP) course 2019. Disponible en: https://gcp.nidatraining.org/eng
dcterms.referencesDuque-Ortiz D. Diálogos Nacionales sobre Ética de la Investigación. Memorias 2013-2014. Colombia: Departamento Administrativo de Ciencia, Tecnología e Innovación; 2015.spa


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 InternationalExcept where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 International